CSL's gene therapy for haemophilia B HEMGENIX (etranacogene dezaparvovec) has become the first treatment approved to be funded via the UK's 'Innovative Medicines Fund'. …
CSL's gene therapy becomes the first funded via the UK's 'Innovative Medicines Fund'
July 5, 2024 Latest NewsBioPharma
Latest Video
New Stories
-
Committee backs J&J CAR-T but redirects price negotiation with four-year proposal
July 8, 2024 - - Latest News -
Where does the system end if statements like this become a feature of our decision-making?
July 8, 2024 - - Latest News -
Pharmac launches first consultation for medicines after funding boost
July 8, 2024 - - Latest News -
Committee recommends major overhaul of diabetes management and access
July 5, 2024 - - Latest News -
New report reveals strong growth in valuations of local life science companies
July 5, 2024 - - Latest News -
Merck’s record support for the Australian Multiple Sclerosis Community
July 5, 2024 - - Latest News -
CSL's gene therapy becomes the first funded via the UK's 'Innovative Medicines Fund'
July 5, 2024 - - Latest News